BioNano Genomics logo
BioNano Genomics BNGO
$ 0.98 3.16%
report update icon

Quarterly report 2026-Q3
added 11-10-2026

BioNano Genomics Market Cap | BNGO

As of November 19, 2026 BioNano Genomics has a market cap of $ 5.34 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap BioNano Genomics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
7.95 M 3.55 M 683 K 37 M 614 M 1.47 B 37.4 M 40.8 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.47 B 683 K 276 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Diagnostics research industry

Issuer Market Cap Price % 24h Market Cap Country
Fluidigm Corporation Fluidigm Corporation
FLDM
481 M - 1.08 % $ 308 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
10.1 B $ 194.96 -0.03 % $ 15.3 B irlandaIrlanda
Senseonics Holdings Senseonics Holdings
SENS
351 M $ 9.76 -3.99 % $ 407 M usaUSA
Sotera Health Company Sotera Health Company
SHC
4.75 B $ 16.27 1.34 % $ 4.62 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
5.85 M $ 0.2 1.99 % $ 266 K usaUSA
Precipio Precipio
PRPO
38.4 M $ 18.8 -1.93 % $ 30.2 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
7.87 B - - $ 10.7 B usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
30.3 B $ 29.82 -0.23 % $ 28.3 B niderlandNiderland
DarioHealth Corp. DarioHealth Corp.
DRIO
32.8 M $ 1.42 23.48 % $ 5.66 M israelIsrael
Thermo Fisher Scientific Thermo Fisher Scientific
TMO
196 B $ 691.66 0.71 % $ 261 B usaUSA
Myriad Genetics Myriad Genetics
MYGN
409 M $ 5.54 -0.09 % $ 513 M usaUSA
ENDRA Life Sciences ENDRA Life Sciences
NDRA
7.41 M $ 4.04 2.93 % $ 5.35 M usaUSA
RadNet RadNet
RDNT
5.62 B $ 72.01 -3.88 % $ 5.41 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
8.52 B $ 49.57 -0.37 % $ 10.8 B niderlandNiderland
NeoGenomics NeoGenomics
NEO
1.48 B $ 15.31 0.36 % $ 1.96 B usaUSA
OPKO Health OPKO Health
OPK
1.04 B $ 1.7 4.63 % $ 1.28 B usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
498 M $ 1.85 1.65 % $ 555 M usaUSA
Neogen Corporation Neogen Corporation
NEOG
2.51 B $ 11.08 1.61 % $ 2.41 B usaUSA
Personalis Personalis
PSNL
431 M $ 14.97 1.15 % $ 1.34 B usaUSA
Quidel Corporation Quidel Corporation
QDEL
10.6 B $ 9.62 -2.53 % $ 405 M usaUSA
Centogene N.V. Centogene N.V.
CNTG
10.7 M - -6.23 % $ 30.6 M germanyGermany
Neuronetics Neuronetics
STIM
81.1 M $ 1.25 -1.95 % $ 82.4 M usaUSA
Trinity Biotech plc Trinity Biotech plc
TRIB
194 M $ 5.83 -3.08 % $ 2.09 B irlandaIrlanda
Global Cord Blood Corporation Global Cord Blood Corporation
CO
304 M - - $ 399 M chinaChina
Genetic Technologies Limited Genetic Technologies Limited
GENE
133 M - - $ 7.1 B australiaAustralia
Genetron Holdings Limited Genetron Holdings Limited
GTH
404 M - 0.12 % $ 80.1 M chinaChina
Exagen Exagen
XGN
70.1 M $ 3.91 3.99 % $ 84.3 M usaUSA
VolitionRx Limited VolitionRx Limited
VNRX
25.2 M $ 0.18 -4.72 % $ 22.6 M singaporeSingapore
Waters Corporation Waters Corporation
WAT
19.7 B $ 466.25 3.66 % $ 27.8 B usaUSA
Aspira Women's Health Aspira Women's Health
AWH
3.03 M - -6.19 % $ 10.5 M usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
4.33 M - - $ 9.42 M israelIsrael
Exact Sciences Corporation Exact Sciences Corporation
EXAS
19.5 B - - $ 19.8 B usaUSA
National Research Corporation National Research Corporation
NRC
315 M $ 26.17 1.08 % $ 586 M usaUSA
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
6.57 B $ 116.3 3.84 % $ 7.28 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
3.1 M - -2.3 % $ 19.4 M usaUSA
OpGen OpGen
OPGN
9.12 M - -16.95 % $ 1.54 M usaUSA
PerkinElmer PerkinElmer
PKI
14.1 B - -0.91 % $ 14.7 B usaUSA
Soleno Therapeutics Soleno Therapeutics
SLNO
2.08 B - - $ 2.69 B usaUSA
Enzo Biochem Enzo Biochem
ENZ
57.5 K - -8.98 % $ 14.8 K usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
22.7 M - 5.66 % $ 22.7 M britainBritain
DexCom DexCom
DXCM
25.5 B $ 82.53 0.6 % $ 32.2 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
1.38 B - - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
844 M - - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
4.03 M - -61.36 % $ 2.46 M usaUSA
Celcuity Celcuity
CELC
5.37 B $ 55.51 -3.86 % $ 2.6 B usaUSA
T2 Biosystems T2 Biosystems
TTOO
7.78 M - -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
9.41 B - - $ 4.46 B usaUSA
Biocept Biocept
BIOC
5.93 M - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
511 M - - $ 21.2 M usaUSA
Quotient Limited Quotient Limited
QTNT
237 M - -11.32 % $ 1.1 M schweizSchweiz